ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 227

Increasing Fat-Mass May Reverse Bone Loss As Detected By DXA Scan

William Hedges1 and Marwan Bukhari2,3, 1Foundation Programme, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, 2Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 3Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Bone density, Data analysis, Dual energy x-ray absorptiometry (DEXA) and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis: Osteoporosis: Pathogenesis, Epidemiology and Diagnosis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Low body mass index (BMI) is a known risk factor for loss of bone mineral density (BMD). It is a part of the FRAX ™ 10-year fracture risk stratification tool developed by the World Health Organisation. It is also known that weight loss through dieting decreases BMD, whilst weight loss through exercise preserves it. The effects of fat-mass and change in fat-mass have not been examined extensively. This could have implications for health advice given to those at significant risk of fragility fractures. This study aimed to identify factors influencing change in bone density related to fat-mass and any confounders.

Methods:

Data were analysed from patients having dual-energy X-ray absorptiometry (DXA) assessment between 2007 and 2010. Patients were included if they had multiple scans which included measurements of lean mass and fat mass. Our scanners limited these to scans of the AP spine. Linear regression was performed to determine the relationship between changes in fat mass and BMD. A backwards stepwise linear regression model was fitted with inclusion of confounders including: sex, risk factors, previous fractures, baseline BMI and age at menopause.

Results:

23,239 patients were included in the study, of which 702 met our inclusion criteria. This included 93 males (13%) and 609 females (87%). Mean age at first scan in the whole cohort was 64.5 years (SD11.2). The mean interval between scans was 3.0 years (SD 0.89). Step-wise linear regression identified a positive correlation between increasing fat-mass and t-score per unit time between scans (coefficient 28.4, p<0.01 95%CI 26.6-30.1). Controlling for the above factors didn't alter the results. We identified previous pelvic and femur fractures (p<0.05) and history of inflammatory diseases (p<0.05) as independent risk factors influencing bone density related to fat mass. This relationship was true for patients that were underweight (BMI <18.5), normal weight (BMI 18.5-25), and overweight patients (BMI >25).

Conclusion:

Increasing fat mass between DEXA scans is associated with an increase in t-scores. Other factors associated with increasing fat-mass include previous pelvic and femur fractures, as well as history of inflammatory disease. However, excessive fat-mass is associated with increased cardiovascular (CVD) and metabolic disease states. Increasing fat-mass is therefore not viable for all patients. Those at particular risk of fragility fractures and not CVD, e.g. BMI<18.5, may be able to improve their long-term risk by gaining weight.

 


Disclosure:

W. Hedges,
None;

M. Bukhari,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increasing-fat-mass-may-reverse-bone-loss-as-detected-by-dxa-scan/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology